Description
Urapidil is an α1-adrenergic receptor antagonist and 5-HT1A receptor agonist. Urapidil exhibits antihypertensive activity, inducing vasodilation and decreasing blood pressure without causing reflex tachycardia.
Urapidil is an α1-adrenergic receptor antagonist and 5-HT1A receptor agonist. Urapidil exhibits antihypertensive activity, inducing vasodilation and decreasing blood pressure without causing reflex tachycardia.
| Cas No. | 34661-75-1 |
|---|---|
| Purity | ≥98% |
| Formula | C20H29N5O3 |
| Formula Wt. | 387.48 |
| Chemical Name | 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]- amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione |
| IUPAC Name | 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione |
| Synonym | Ebrantil |
| Melting Point | 156-158°C |
| Solubility | Soluble in H2O. |
| Appearance | White Crystal Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | U6801 MSDS PDF |
|---|---|
| Info Sheet | U6801 Info Sheet PDF |
Santiveri X, Ledesma M. Urapidil in anesthesiology: pharmacology and indications. Rev Esp Anestesiol Reanim. 1998 May;45(5):189-97. PMID: 9646668.
van Zwieten PA, Chalmers JP. Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc Drugs Ther. 1994 Dec;8(6):787-99. PMID: 7742257.